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Abstract
Arabidopsis CRINKLY4 (ACR4) is a receptor-like kinase (RLK) involved in the global devel-
opment of the plant. The Arabidopsis genome encodes four homologs of ACR4 that contain
sequence similarity and analogous architectural elements to ACR4, termed Arabidopsis
CRINKLY4 Related (AtCRRs) proteins. Additionally, a signaling module has been previous-
ly proposed including a postulated peptide ligand, CLE40, the ACR4 RLK, and the WOX5
transcription factor that engage in a possible feedback mechanism controlling stem cell dif-
ferentiation. However, little biochemical evidence is available to ascertain the molecular as-
pects of receptor heterodimerization and the role of phosphorylation in these interactions.
Therefore, we have undertaken an investigation of the in vitro interactions between the in-
tracellular domains (ICD) of ACR4, the CRRs andWOX5. We demonstrate that interaction
can occur between ACR4 and all four CRRs in the unphosphorylated state. However, phos-
phorylation dependency is observed for the interaction between ACR4 and CRR3. Further-
more, sequence analysis of the ACR4 gene family has revealed a conserved ‘KDSAF’motif
that may be involved in protein-protein interactions among the receptor family. We demon-
strate that peptides harboring this conserved motif in CRR3 and CRK1are able to bind to
the ACR4 kinase domain. Our investigations also indicate that the ACR4 ICD can interact
with and phosphorylate the transcription factor WOX5.
Introduction
Mammalian systems have acquired signal transduction mechanisms via the use of receptor ty-
rosine kinases (RTK) to coordinate cellular processes such as proliferation, migration, differen-
tiation, and cell-cycle control [1]. RTKs are comprised of an extracellular ligand binding
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domain, a single membrane spanning region, and an intracellular tyrosine kinase domain.
The classical paradigm of RTK activation involves ligand binding to the extracellular domain
and receptor homo- or heterodimerization through interactions among receptor subdomains
[1–5].
Similar to RTKs in architecture, plant receptor-like kinases (RLKs) contain an extracellular
ligand binding domain, a transmembrane helix, and an intracellular serine/threonine kinase
domain and are involved in various plant signaling processes [6–9]. It is evident from structural
and biochemical studies that mechanisms of RLK signaling are similar to RTKs where ligand
binding leads to receptor activation and initiation of an intracellular signaling cascade. Further-
more, it has been demonstrated that RTKs can form homo- or heterodimeric receptor com-
plexes that can elicit differential signaling cascades based on intracellular kinase
autophosphorylation and recruitment of specific signaling molecules, as classically exemplified
by the EGF receptor family [10–12]. Among RLKs, the heterodimeric interactions between
BRI1 and BAK1 and its effects on downstream signaling are well documented [13–14].
Arabidopsis CRINKLY4 (ACR4) is a RLK involved in the proper growth and development
of the plant [15–18]. We have recently reported on some significant in vitro biochemical prop-
erties of the ACR4 intracellular domain including its kinase activity, oligomerization proper-
ties, and the identification of at least 16 autophosphorylation sites encompassing all three
subdomains [19]. Genetic and biological experiments have detailed the functional properties of
ACR4 in developing and mature tissues. The RLK primarily effects epidermal formation in the
leaves, sepal margins, and reproductive tissues of the plant [15–16, 18]. Elegant cell biology
studies indicate ACR4 influences root development and morphology. Thus, ACR4 is required
for columella stem cell differentiation in the root apical meristem and is essential for proper lat-
eral root formation [20–21]. A signaling module has been proposed including a postulated pep-
tide ligand, CLE40, the ACR4 RLK, and the WOX5 transcription factor that engage in a
possible feedback mechanism controlling stem cell differentiation similar to CLAVATA signal-
ing in the shoot apical meristem [22–23]. More recently, ACR4 and CLAVATA1 (CLV1) have
been shown to be involved in the same pathway to restrict root stemness at the root tip. Impor-
tantly, there is now evidence that shows ACR4 and CLV1 can form homo- and heterodimers
and regulate root meristem maintenance in response to the CLE4 signaling peptide [24].
The Arabidopsis genome encodes four homologs to ACR4, termed Arabidopsis CRINKLY4-
Related proteins (AtCRRs), which are similar in sequence and architecture to ACR4 [17]. Both
CRR1 and CRR2 have been described as kinase-defective due to the absence of the activation
loop, a stretch of sequence critical for activity [17, 25]. Recombinant CRR2 kinase domain has
been shown to have little to no activity in vitro [17] but can be phosphorylated by ACR4 kinase,
suggesting a possible intermolecular association. Functional redundancy has been suggested to
account for the five members of the ACR4 gene family [17]. Developing Arabidopsis roots
showed significant enhancement of lateral root densities in acr4/crr triple mutant backgrounds
compared to acr4 single mutants, suggesting that the CRRs may be able to compensate for loss
of ACR4 function in restricting lateral root initiation [21]. Various genetic and cell biology ex-
periments have hinted at multiple players/interactions potentially involved in the ACR4 signal-
ing network. However, the molecular aspect of these interactions with potential membrane-
associated or cytosolic protein targets at the cell surface is vaguely understood.
To better understand the role of protein-protein interactions mediated by ACR4 in vivo, we
have undertaken an in vitro study of the interactions between the intracellular domains (ICD)
of ACR4 and the CRRs. We have utilized in vitro kinase assays to demonstrate that ACR4 can
phosphorylate the CRRs and can interact with all four CRRs in the unphosphorylated state.
However, phosphorylation dependency is observed for the interaction between ACR4 and
CRR3. We also demonstrate through peptide binding assays that a conserved ‘KDSAF’motif in
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the helix-C region of CRR3 and CRK1 can bind to the ACR4 kinase domain. For the first time,
we also provide evidence for the direct interaction of ACR4 ICD with WOX5. Importantly,
ACR4 can phosphorylate WOX5 in vitro and mass spectrometry analysis has identified four
phosphorylation sites within the WOX5 protein sequence.
Materials and Methods
Vector construction
Constructs of SUMO fused ACR4 ICD (sACR4), mutant ACR4 derivatives, and the CRR ICDs
(sCRRs) were prepared as described in Meyer et al [26]. The ICD of ACR4 was also cloned as a
C-terminal fusion to Maltose Binding Protein (MBP). First, the ACR4 ICD was PCR amplified
using the forward primer 5’- GCGGGCGCGGCCTTAAGGTACAGATTGAGGAATTGT-3’
and the reverse primer 5’- CCAACCGCGGCCTCAGAAATTATGATGCAAGAACAAG-3’.
The PCR amplified gene was then cloned by standard ligation independent cloning (LIC) pro-
cedures into an in-house modified pMAL-C2E vector generated for LIC and containing a 6X
His tag at the amino-terminus of MBP. DNA sequencing confirmed correct insertion of the
ACR4 ICD gene into the pMAL-C2E vector.
The WOX5 cDNA was synthesized (GenScript) with codon optimization for E. coli expres-
sion and synthesized. The gene was cloned as a C-terminal fusion to MBP (mWOX5) using the
forward primers 5’-GCGGGCGCGGCCTTAGGTAGTTTTAGTGTGAAAGGC-3’ and the re-
verse primer 5’-CCAACCGCGGCCTCATTACAGAAACGACAGACGCAGG-3’. The result-
ing insert was cloned as describe above, into an in-house modified pMAL-C2E vector
generated for LIC but contained a 6X His tag at the carboxy-terminus to aid in purification of
full length mWOX5 protein.
Mutagenesis
To generate the inactive kinase mutants, the catalytic Asp residue of each kinase was mutated
to Ala. The vectors encoding the SUMO-fused intracellular domains of the CRRs (sCRRs) were
mutagenized using the QuickChange Lightning Multi Site-Directed Mutagenesis Kit (Strata-





The inactive sACR4–2m vector was prepared as previously described (26). Similarly, mu-
tants of ACR4 with Ala mutations in the LLSLL motif in the N-terminal lobe were made by
first creating the mutant KC-LLAAL using the primer 5’-CTCAACCATGCT-
CATCTTCTTGCCGCTCTTGGATACTGTGAAGAATGG-3’. This mutant was subsequently
used as a template to make the KC-AAAAA mutant (all residues in the LLSLL motif replaced
with Ala) using the primer 5’-CTCAACCATGCTCATGCTGCTGCCGCTGCTGGA-
TACTGTGAAGAATGG-3’.
Protein expression and purification
Expression and purification was performed as described by Meyer et al [26]. Proteins were ex-
pressed for 5h in Rosetta2 (DE3) pLysS (Novagen) cells at 20°C with 1mM IPTG induction
and the proteins purified as described (26). Briefly, pellets from 250 ml cultures were resus-
pended and lysed in 10 ml Lysis Buffer (50 mM Tris-HCl pH 7.4, 150 mMNaCl, 40 mM
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imidazole, 0.1% Triton X-100, 1 mMDTT, and 1 mM AEBSF). After centrifugation the super-
natant lysate was incubated with Ni-NTA Superflow resin (Qiagen) and bound proteins eluted
with Elution Buffer (50 mM Bis-Tris pH 7.2, 50 mMNaCl, 150 mM imidazole, 1 mMDTT) on
ice. Protein quantities were determined by the Bradford method [27] and yields typically ran-
ged from 1–5 mg of protein.
To isolate the MBP fused ACR4 kinase (mACR4), the vector was transformed into T7 Ex-
press cells (New England Biolabs) and plated on Ampicillin plates. Protein expression and pu-
rification was performed as described above, except Ampicillin (100 μg/ml) was used in
cultures. Further purification of the IMAC enriched protein was performed by gel filtration on
an FPLC system using the 10/300 Superdex G200 column (GE Healthcare) equilibrated with
Column Buffer (50 mM Tris-HCl 7.4, 100 mMNaCl, 1 mMDTT). The MBP-fused WOX5
(mWOX5) protein was also expressed and purified as described above.
Circular Dichroism (CD) Measurements
Far UV CD spectra of sACR4 KC and the mutant, sACR4 KC-AAAAA were recorded with a
Jasco-710 spectropolarimeter in a 0.1 cm path length cuvette with excitation wavelengths rang-
ing from 190–260 nm. The protein sample (A280 of ~1) was prepared in 10 mM Tris-HCL
(pH 7.4) buffer containing 0.1 mM TCEP.
Peptide Synthesis
Synthetic peptides for a 15 amino-acid segment corresponding to (a) the sequence
468DTRSSKDSAFTKDNG482 in the juxtamembrane domain of ACR4 ICD (b) the sequence
487HRRADKDSAFVNELES502 in the C-helix of the kinase domain of CRK1 and (c) the se-
quence 533KKFQEKETAFDSEIAF548 in the C-helix of the kinase domain of CRR3 were syn-
thesized with a biotin tag at the amino terminus (Genscript, USA).
Pull-down assays
The mACR4 kinase (20 μg per reaction) was used as bait to pull out sCRR kinase domains
(30 μg per reaction). Depending on the assay conditions, proteins were autophosphorylated in
proteins 200 μl Kinase Buffer (20 mM Bis-Tris pH 7.2, 25 mM NaCl, 5 mMMnCl2, 1 mM
DTT) and 100 μMATP. Proteins were allowed to autophosphorylate for 1 h prior to pull-
down experiments. Potential binding partners were added to each reaction and Binding Buffer
(50 mM Tris-HCl pH 7.4, 150 mMNaCl, 1 mM DTT, 0.02% NP-40) was added to a final vol-
ume of 500 μl. Proteins were incubated on a rotator for 1 h at room temperature. 25 μl bed vol-
ume of amylose resin was added to each reaction and incubated an additional 1 h on a rotator
at room temperature. Reactions were spun down at 1,000 rpm for 30 sec to pellet the resin. The
resin was washed three times with Binding Buffer to remove unbound protein. After the third
wash, the supernatant was removed and 100 μl of Laemmli buffer was added to the resin. The
resin/protein mixture was boiled at 95°C for 5 min then centrifuged at max speed to pellet
resin. 10 μl of supernatant from each reaction was separated by 12% SDS-PAGE and proteins
were analyzed by coomassie staining or by western blots with polyclonal anti-MBP (Rockland
Immunochemicals, 1:3,000 dilution) or anti-SUMO (Rockland Immunochemicals, 1:2,000
dilution).
The kinase active proteins were used for conditions requiring phosphorylated or unpho-
sphorylated proteins of both interacting partners. The inactive kinase mutants were used for
conditions which required one protein of the interaction pair to be unphosphorylated. First,
mACR4 protein was autophosphorylated as described above, immobilized on 25 μl of amylose
resin, and washed three times with Binding Buffer to remove excess ATP.
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mWOX5 protein was used to pull down sACR4 protein similar to the protocol outlined
above. Briefly, 20 μg of mWOX5 protein was incubated with 30 μg of sACR4 protein. Depend-
ing on the assay conditions, sACR4 was autophosphorylated as described above. mWOX5 and
sACR4 were added to a reaction and Binding Buffer was added to a final volume of 500 μl. Pro-
teins were incubated and pulled-down as described above. 10 μl of supernatant from each reac-
tion was separated by 10% SDS-PAGE and proteins were analyzed by coomassie staining or by
western blots with polyclonal anti-MBP (Rockland Immunochemicals, 1:3,000 dilution) or
anti-SUMO antibody (Rockland Immunochemicals, 1:2000 dilution).
Gel filtration studies
Purified sACR4 protein was incubated with a sCRR protein at equimolar concentrations to de-
termine possible interactions. 5 μM sACR4 was incubated with 5 μM of binding partner in 500
μl of Column Buffer (50 mM Tris pH 7.4, 100 mMNaCl, 1 mMDTT, and 100 μMMnCl2) for
1 h at room temperature. Protein mixtures were then loaded onto a Global 10/300 Superdex G-
200 Column (GE Healthcare) coupled to an AKTA FPLC system. Proteins were passed through
the column at a flow rate of 0.5ml/min and 1 ml fractions were collected. Proteins in subse-
quent fractions were analyzed by 12% SDS-PAGE.
In vitro phosphorylation assays
Active sACR4 protein was incubated with the inactive sCRRm proteins. For each reaction 1 μg
of sACR4 was incubated with ~1 μg of sCRRm in 20 μl of Kinase Buffer (20 mM Bis-Tris pH
7.2, 25 mM NaCl, 5 mMMnCl2, 1 mM DTT, 25 μMATP) supplemented with 2 μCi of [γ-
32P]
ATP (Perkin Elmer, 6,000 Ci/mmol). Proteins were incubated at room temperature for 1 h. Re-
actions were then terminated with the addition of 4X SDS sample buffer and boiled. Proteins
were separated by 12% SDS-PAGE and radioactive bands were analyzed by phosphorimaging.
A modified in vitro phosphorylation assay was used for sACR4 and mWOX5 since they mi-
grate similarly on an SDS-PAGE gel. Phosphorylation proceeded in a 50 μl reaction containing
2 μg of sACR4 and 30 μg of mWOX5 (or 30 μg of MBP as a control) in Kinase Buffer as de-
scribed above. Following incubation, mWOX5 protein was pulled-down using amylose resin.
The phosphorylation reactions were brought up to 500 μl with Wash Buffer (50 mM Tris-HCl
pH 7.4, 150 mMNaCl, 1 mMDTT, and 0.5% NP-40). 25 μl bed volume of amylose resin was
added to each reaction and incubated an additional 1 h on a rotator at room temperature. Reac-
tions were spun down to pellet the resin and the supernatant was removed. The resin was
washed five times with 500 μl of Wash Buffer to remove unbound protein. After washing, the
supernatant was removed and 100 μl of Laemmli buffer was added to the resin. The resin/pro-
tein mixture was boiled at 95°C for 5 min then centrifuged to pellet resin. Proteins from each
reaction were separated by 10% SDS-PAGE and analyzed by phosphorimaging.
Peptide overlay assays
These were performed as described previously (26). Briefly, the target proteins (sACR4 KC,
sACR4 KC-AAAAA and SUMO) were blotted on to a nitrocellulose membrane after separa-
tion by 12% SDS-PAGE. After staining with a 0.1% Ponceau S solution, bands were then cut
from the blot and destained. After washing and blocking steps, individual blotted bands were
then added to microfuge tubes containing 1 ml of the appropriate peptide (synthesized with an
N-terminal biotin tag) at a final concentration of 100 μM in Tris-HCl buffer at pH 8.0. Blots
were incubated on a rotating platform for 2 h at room temperature, followed by two washes
with TBS at 5 min intervals. Peptides were also incubated with SUMO protein as a control.
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Peptide binding was detected by incubation with streptavidin conjugated Alkaline Phosphatase
(AP) (Pierce) and AP Substrate kit (Bio-Rad) as described previously [26].
Peptide binding assays
The binding of ‘KDSAF’ peptides to sACR4 KC, sKC-AAAAA and SUMO (control) protein
was performed as described previously [26]. Briefly, the proteins were first immobilized in a 96
well nickel coated plate (XpressBio) by incubating 100 μl of ~1 μM protein sample in TBS +
0.1% Tween20 for 1 h at room temperature. After a few washing steps, wells were subsequently
incubated with 50 μl of the appropriate peptide solution (200 μM) on an orbital shaker for 2 h
at room temperature. Excess peptide solution in the wells was then discarded, washed with
TBS to remove unbound peptides and incubated with 50 μl of a streptavidin-AP solution
(1:500) for 1 h at room temperature. Colorimetric detection of peptide binding was initiated by
adding 100 μl of a pNPP solution (100 mM ethanolamine pH 9.8, 10 mM pNPP) to each well.
The reactions were allowed to incubate 5 min with occasional manual shaking. Reactions were
terminated with the addition of 50 μl of 2N NaOH to each well. 100 μl of each reaction was di-
luted with 400 μl of water and absorbance at 405 nm measured. Each peptide binding experi-
ment was performed in triplicate and data represented as the mean ± the S.E. Data were
corrected for dilution factor and subtracting the absorbance of the control (SUMO) well from
the experimental samples.
Identification of WOX5 phosphorylation sites by mass Spectrometry
This was performed as described by Meyer et al. [19]. Briefly, tryptic peptides were generated
from the reduced-alkylated protein using Sequencing Grade Modified Trypsin (Promega). The
resulting peptides were desalted on a SOURCE 15 RPC column (GE Healthcare) and eluted in
90% acetonitrile, 0.1% TFA. The eluted peptides were then dried down in a vacuum centrifuge.
Phosphopeptides were enriched using the PHOS-Select Ga3+ Silica Spin Column kit (Supelco)
according to the kit instructions. The complex peptide mixtures were analyzed using high-
resolution nano-LC-MS on a hybrid mass spectrometer consisting of a linear quadrupole ion-
trap and an Orbitrap (LTQ-Orbitrap XL, Thermo Fisher Scientific). Chromatographic separa-
tions were performed using a NanoLC-1D Plus (Eksigent) for gradient delivery and a cHiPLC-
nanoflex (Eksigent) containing a 15 cm x 75 μmC18 column (ChromXP C18-CL, 3 μm, 120 Å,
Eksigent). The liquid chromatograph was interfaced to the mass spectrometer with a nanos-
pray source (PicoView PV550; New Objective). The survey scans (m/z 350–2000) (MS1) were
acquired at high resolution (60,000 atm/z = 400) in the Orbitrap and the MS/MS spectra (MS2)
were acquired in the linear ion trap at low resolution, both in profile mode. The MS1 scan was
followed by one MS2 event with collision activation in the ion trap (parent threshold = 10000;
isolation width = 4.0 Da; normalized collision energy = 30%; activation Q = 0.250; activation
time = 30 ms). The following ion source parameters were used: capillary temperature 200°C,
source voltage 3.3 kV, source current 100 μA, capillary voltage 34 V, and the tube lens at 125 V.
Data Analysis
The MS2 spectra were analyzed by searching against theWOX5 sequence and expert manual in-
terpretation. The exact masses of the phosphopeptide and fragmentation ions were calculated
using the MS-Product utility within Protein Prospector (http://prospector.ucsf.edu). For data-
base searches, the LC-MS files were processed using MASCOT Distiller (Matrix Science, version
2.3.0.0) with the settings previously described (19). The resulting MS2 centroided files were used
for database searching with MASCOT, version 2.1.6, against a custom, in-house database con-
taining 266 disparate proteins including theWOX5 sequence using the following parameters:
Intermolecular Interactions Mediated by ACR4 Kinase Domain
PLOS ONE | DOI:10.1371/journal.pone.0118861 March 10, 2015 6 / 26
enzyme, trypsin; MS tolerance = 15 ppm, MS/MS tolerance = 0.8 Da with a fixed carbamido-
methylation of Cys residues and the following variable modifications: oxidation (Met) and phos-
phorylation (Ser, Thr, and Tyr); MaximumMissed Cleavages = 9; and 1+, 2+ and 3+ charge
states. For analysis of the tandem spectra from spectral acquisitions in the Orbitrap (MS2), the
raw files were processed using MASCOT Distiller (Matrix Science, Oxford, UK) with the follow-
ing settings: 1) as described previously [19]. The searched data was analyzed in Scaffold_4.4.1.1
(Proteome Software). A 0.1% false discovery rate (FDR) was calculated using protein probabili-
ties estimated from the results of the Protein Prophet algorithm with threshold settings of 95%
for peptides and proteins and a minimum of two peptides per protein.
Hydrogen/Deuterium Exchange Mass Spectrometry
Differential, solution phase HDX experiments were performed to detect the conformational
change of sACR4 induced by the addition of sCRK1. Each exchange reaction was initiated by
incubating 4 μl of protein complex (with or without sCRK1) with 16 μl of D2O protein buffer
(50 mM Bis Tris pH 7.2, 25 mM NaCl, 0.1 mMMnCl2, 1 mMDTT) for a predetermined time
(10, 30, 60, 120, 900, and 3600 s) at 4°C. The exchange reaction was quenched by mixing with
30 μl of 3 M urea, 1% TFA at 1°C. The mixture was passed across an in-house packed pepsin
column (2 mm X 2 cm) at 200 μl/min and digested peptides were captured onto a 2mm X 1cm
C8 trap column (Agilent) and desalted (total time for digestion and desalting was 3 min). Pep-
tides were then separated across a 2.1 mm X 5 cm C18 column (1.9μHypersil Gold, Thermo
Scientific) with linear gradient of 4%–40% CH3CN, 0.1% formic acid, over 5 min. Protein di-
gestion and peptide separation were performed within an ice water bath to reduce D/H back
exchange. Mass spectrometric analyses were carried out with capillary temperature at 225°C,
and data were acquired with a measured resolving power of 100,000 at m/z 400. Three repli-
cates were performed for each on-exchange time point.
Peptide Identification and HDX Data Processing
MS/MS experiments were performed with a LTQ Orbitrap mass spectrometer (ThermoFisher).
Product ion spectra were acquired in a data-dependent mode and the six most abundant ions
were selected for the product ion analysis. The MS/MS .raw data files were converted to .mgf
files and then submitted to Mascot (Matrix Science, London, UK) for peptide identification.
Peptides included in the peptide set used for HDX had a MASCOT score of 20 or greater. The
MS/MS MASCOT search was also performed against a decoy (reverse) sequence and ambigu-
ous identifications were ruled out. The MS/MS spectra of all of the peptide ions from the MAS-
COT search were further manually inspected, and only those verifiable are used in the
coverage. The intensity weighted average m/z value (centroid) of each peptide isotopic enve-
lope was calculated with HD Desktop [28]. The deuterium level was calculated as described
previously [29]. Deuterium level (%) = {[m(P)—m(N)]/[m(F)—m(N)]} X 100%, where m(P),
m(N) and m(F) are the centroid value of partly deuterated peptide, nondeuterated peptide, and
fully deuterated peptide, respectively. The correction of accounting for the known 80% deuteri-
um content of the on-exchange buffer was made. No back exchange correction was made and
all values are therefore reported as relative.
Results
In vitro interactions between the ACR4 and CRR ICDs
We examined potential interactions between the ICDs of ACR4 and the CRRs by gel filtration
chromatography (Fig. 1) using recombinantly expressed SUMO-tagged proteins. Pairs of
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unphosphorylated proteins were incubated together at equimolar concentrations (5 μM each)
and subjected to gel filtration. It is evident by this analysis that purified sACR4 protein is pre-
dominantly monomeric, although there is evidence of higher order oligomers (Fig. 1A and
inset). This is in agreement with our previous gel filtration studies of the NusA fused ACR4
ICD [19] and indicates that the solubility tag does not influence oligomerization. When
sACR4 was incubated with sCRR2 or sCRK1, the gel filtration profile clearly indicated interac-
tions between these proteins. Thus, the elution profiles showed the formation of oligomeric
complexes containing sACR4/sCRR2 (Fig. 1B, left panel) and sACR4/sCRK1 (Fig. 1D, left
panel) when analyzed by SDS-PAGE (Fig. 1B and D, left panels inset). Importantly, neither
sCRR2 (Fig. 1B, right panel) nor sCRK1 (Fig. 1D, right panel) by themselves showed any evi-
dence of self-association in the absence of phosphorylation at the concentrations examined
during gel filtration. These results suggest that ICDs of CRK1 and CRR2 can interact with the
ICD of ACR4 in the absence of phosphorylation. No oligomeric complexes were observed
with the sACR4/sCRR3 samples. The interaction between sACR4 and sCRR1 could not be
studied by gel filtration owing to the propensity of sCRR1 to aggregate under
these conditions.
Fig 1. Gel filtration analysis of ICD interactions. Protein-protein interactions between the ICDs of ACR4 and the CRR binding partners were assessed by
gel filtration on a Superdex G-200 column. (A) ACR4 elution profile demonstrating the protein primarily elutes as a monomer, but has the propensity to form
higher order oligomers. (B-D) the elution profiles of the CRRs incubated alone (right panels) or with ACR4 (left panels). Insets depict 12% SDS-PAGE gels of
eluted protein fractions.
doi:10.1371/journal.pone.0118861.g001
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Effects of phosphorylation on heteromeric interactions
The kinase domains of many plant receptors are known to undergo phosphorylation during re-
ceptor activation and oligomerization [30–32]. To determine if the associations between the
ICD of ACR4 and the ICDs of the CRRs were influenced by phosphorylation, in vitro pull-
down experiments were performed with various combinations of autophosphorylated kinases
(Fig. 2A-D). The MBP-fused ICD of ACR4 (mACR4) protein (~0.4 μM) was used as the bait
and the sCRRs proteins (~1 μM) were used as the prey. Therefore, the target proteins were in ~
2.5 molar excess over the mACR4 bait protein. In the naïve, unphosphorylated state, mACR4
was able to pull out all of the naïve sCRR proteins (Fig. 2A). This suggests that these kinases
possess the intrinsic propensity to hetero-oligomerize in the unphosphorylated state. It is
worth noting that this experiment was able to demonstrate an interaction between the naïve
mACR4 and sCRR3 when the concentration of sCRR3 was in excess of sACR4, suggesting that
concentration effects may indeed drive hetero-association of these two proteins not seen in our
gel filtration studies that were performed at equimolar protein concentrations. Additionally,
the SUMO tagged ACR4 (sACR4) intracellular domain was pulled out by mACR4 confirming
previous sedimentation velocity experiments using the NusA fused ACR4 ICD that indicated
kinase domain oligomerization in the absence of phosphorylation [19]. Control reactions
showed these interactions were specific towards the ICDs and were not due to interactions
with the SUMO and MBP solubility tags or nonspecific binding of fusion proteins to the amy-
lose resin (data not shown). The presence of mACR4 in each reaction was confirmed with
western blots using polyclonal, anti-MBP antibody (Fig. 2A, lowest panel) and the sCRRs were
confirmed by western blots probed with a polyclonal, anti-SUMO antibody (Fig. 2A-D, lower
panels).
Interestingly, autophosphorylation of the ICDs had striking effects on ACR4 interactions
with the CRR homologs. Loss of interaction occurs between mACR4/sACR4 (Fig. 2B, lane 1).
The fact that phosphorylated mACR4 does not interact with phosphorylated sACR4 supports
our previous observation that ACR4 monomerizes upon autophosphorylation [19]. The inter-
action between phosphorylated mACR4 and phosphorylated sCRK1 is attenuated but not
completely abolished. (Fig. 2B, lane 5). Intriguingly, the interaction between sACR4 and
sCRR3 is completely abolished, demonstrating that autophosphorylation of the ICDs forces
dissociation of these two proteins (Fig. 2B, lane 4). The dissociation may be due to conforma-
tional changes that accompany autophosphorylation [19] and/or electrostatic repulsion due to
increases in net negative charge from autophosphorylation.
The interactions observed between the mACR4/sACR4 and mACR4/sCRR3 showed de-
creased binding ability depending on whether the bait protein (mACR4) or the target protein
(sACR4, sCRR3) was in the phosphorylated state (Fig. 2C and D) as compared to the two ex-
tremes of where the participating proteins are either in the unphosphorylated state (Fig. 2A) or
phosphorylated state (Fig. 2B). These results indicate that autophosphorylation of both part-
ners is required to disrupt the intracellular contact between ACR4/ACR4 and ACR4/CRR3 ki-
nase domains. The fact that mACR4 is able to strongly interact with sCRR1 and sCRR2
regardless of phosphorylation state (Fig. 2A-D), raises the possibility that ACR4 may be able to
signal through the use of dead kinase domains [33–34].
ACR4 can phosphorylate the CRR homologs
Receptor activation through homo- or heterodimerization is accompanied by intra- and inter-
molecular phosphorylation reactions, recruitment of proteins to the intracellular domain of the
receptor and subsequent activation of signaling events inside the cell [1, 10, 14]. Previous stud-
ies have proposed that ACR4 can phosphorylate CRR2 in an in vitro phosphorylation assay
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[17]. We further assessed the ability of ACR4 to phosphorylate the CRRs by incubating the ac-
tive mACR4 kinase with the kinase dead, sCRR mutants (sCRRms) (Fig. 3A). Since CRR3, and
CRK1 have robust kinase activity, we mutated the catalytic Asp [35] of each kinase to Ala in
order to inactivate each enzyme. Although CRR1 and CRR2 have intrinsically very weak kinase
Fig 2. Effect of autophosphorylation on ICD interactions. Pull-down assays were performed to determine the effects of phosphorylation on interactions
between the ICDs of ACR4 and the CRRs. The autophosphorylation status of each protein was varied for individual experiments, (+) denotes
autophosphorylated protein, (-) denotes unphosphorylated protein. In (A), mACR4 (-) and sCRRs (-), (B) mACR4 (+) and sCRRs (+), (C) mACR4 (+) and
sCRRs (-), (D) mACR4 (-) and sCRRs (+). In A-D, proteins were separated by 12% SDS-PAGE (top panels) and the presence of interacting proteins was
determined by anti-SUMO western blot (lower panels). In the bottom panel of A, anti-MBP western blot demonstrates the presence of mACR4 in
each reaction.
doi:10.1371/journal.pone.0118861.g002
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activity attributable to the absence of the activation loop in each protein (data not shown) [17],
to completely eliminate autophosphorylation activity, we also mutated the catalytic Asp in
both CRR1 and CRR2 to Ala. Inactivity of each mutant was confirmed by an in vitro autopho-
sphorylation assay (Fig. 3B). The ACR4 kinase can in fact phosphorylate the intracellular ki-
nase domains of all four CRR homologs in vitro. Amongst the CRRs, the weakest
phosphorylation activity was seen against sCRR1m (Fig. 3A, lane 1) and relatively stronger ac-
tivity was seen against the sCRK1m ICD (Fig. 3A, lane 4). Thus, these in vitro experiments sug-
gest that ACR4 may also have the potential to phosphorylate the CRRs in vivo. No
phosphorylation of the yeast SUMO protein was observed when incubated with sACR4
Fig 3. ACR4 can phosphorylate the ICDs of the CRRs. Active mACR4 was incubated with the inactive sCRRs in an in vitro kinase assay. (A) Upper panel
shows an autoradiogram demonstrating ACR4 can phosphorylate the ICDs of the inactive CRRs. ACR4 cannot phosphorylate the SUMO tag. Lower panel
shows the corresponding coomassie stained gel. (B)Upper panel depicts an autoradiogram showing the inactivity of the sCRRmutants in which their
respective catalytic Asp residues have been mutated to Ala. Lower panel is the corresponding coomassie stained gel showing the presence of each protein.
doi:10.1371/journal.pone.0118861.g003
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indicating that the phosphorylation of the SUMO-tagged CRRs was specific to the intracellular
domain and not to the fusion tag (Fig. 3A, lane 5).
Mapping ACR4/CRK1 interaction sites by H/D exchange
To assess the molecular basis of the ACR4-CRR interactions, we used hydrogen-deuterium ex-
change coupled to mass spectrometry in order to map potential intermolecular interactions
sites within the ACR4 ICD. Hydrogen-deuterium exchange (HDX) is an effective tool to map
in solution protein-ligand interaction sites and determining conformational dynamics of pro-
teins [36–37]. This technique makes advantageous use of backbone amide hydrogens and their
availability for isotopic labeling with deuterium from the solvent. Amide hydrogens undergo-
ing intra- or intermolecular hydrogen bonding have reduced exchange rates when compared to
amide hydrogens exposed to the solvent. Therefore, hydrogen exchanged with deuterium can
be monitored by mass spectrometry to delineate specific regions within a protein sequence that
are solvent accessible. Binding interfaces within a protein complex can be determined by com-
paring HDX rates of the bound and unbound state [38–40]. Consequently, mapping of isotopi-
cally labeled peptides along a given protein sequence provides a general idea of potential
protein-protein interactions sites.
On the basis of the gel filtration, pull-down, and phosphorylation studies, we determined
that CRK1 was a good candidate for mapping potential interactions sites between the unpho-
sphorylated ACR4 and CRK1. The experiment was initially performed with the unbound, apo-
sACR4 protein to determine individual HDX profiles for all peptides produced from the in-
line pepsin digest of the sample. Overall, 100 peptides with overlapping sequence correspond-
ing to the ACR4 ICD were identified in the mass spectrometry analysis of peptic fragments
generated from the apo-sACR4 enzyme. Peptide sequence coverage was ~98% of the ACR4 in-
tracellular domain. This data was then compared to peptide HDX profiles generated from the
holo-sACR4 protein bound to sCRK1 after prior incubation at ratios of 1:1 or 1:3 (see Materials
and Methods). Evaluation of the mass spectrometry data revealed two sites of protection within
the ACR4 ICD. One site, corresponding to the peptic fragment FRTELDL, is a part of helix-C
in the N-terminal lobe of the kinase domain. This region displayed a significant average de-
crease in percent deuteration of 5%. The second peptide, YRLHY, occurs in the C-lobe of the
kinase domain, just downstream of the C-terminal hinge of the activation loop, and showed a
6% average decrease in deuterium uptake compared to apo-ACR4 (Fig. 4). The decrease in deu-
terium uptake is indicative of a significant involvement of these two regions in interfacial con-
tacts between ACR4 and CRK1. Our experiments did not reveal any differences in HD
exchange for peptides corresponding to the JMD or CTD of ACR4. However, further studies
are needed to ascertain the exact role of these subdomains in potential protein-
protein contacts.
‘KDSAF’motif binds ACR4 kinase domain
In a recent paper [26], we showed that a synthetic peptide JMD1, 468DTRSSKDSAFTKDNG482,
derived from the juxtamembrane domain (JMD) of ACR4-ICD could bind to the kinase do-
main in trans, perhaps via the LLSLL sequence motif, and postulated a potential intramolecular
interaction between the juxtamembrane domain and the kinase domain in the ICD. Interest-
ingly, a close scrutiny of the amino acid sequences of ACR4, CRR3 and CRK1 revealed a highly
conserved ‘KD/ESAF’motif (Fig. 5A). The inactive members of the AtCRR family, CRR1 and
CRR2 ICDs, do not contain this motif, suggesting that the ‘KD/ESAF’ region may serve a criti-
cal role in the kinase-active members of the ACR4 family. However, whereas the KDSAF se-
quence is found in the JMD of ACR4, in CRR3 and CRK1 it occurs in the kinase domain
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towards the N-terminal portion of the presumed helix-C region (Fig. 5A). The identification of
conserved KDSAF motifs in ACR4, CRR3 and CRK1 ICDs raised the intriguing possibility that
the association among these proteins could be mediated, at least in part, via this motif.
To test this hypothesis, we synthesized peptides corresponding to the helix-C regions of
CRR3 and CRK1 (Fig. 5A, termed hC peptides), and the JMD1 peptide which contains the
‘KDSAF’motif in ACR4, for use in peptide overlay assays (Fig. 5B). As described in Materials
and Methods, peptide binding was assessed by colorimetric detection using streptavidin conju-
gated Alkaline Phosphatase. Our results unequivocally show direct binding of the ‘KDSAF’
Fig 4. HDX-MS analysis of ACR4/CRK1. Time course of deuterium uptake for two ACR4 peptides, FRTELDL and YRLHY, that demonstrated significant
hydrogen-deuterium exchange rates between the free ACR4 (closed squares) and the ACR4/CRK1 bound (open squares) states. Data represent the mean
(n = 3).
doi:10.1371/journal.pone.0118861.g004
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Fig 5. ‘KDSAF’ peptides bind to the ACR4 kinase. (A) Schematics of the ACR4, CRK1 and CRR3 amino acid sequence. The location of the “KDSAF”motif
sequence in the domain architecture of the respective proteins is indicated by an arrow. (B) The ‘KDSAF’motif containing peptides were incubated with the
sACR4 KC protein to demonstrate specificity of binding towards the ACR4 kinase. A peptide overlay assay showing that the unphosphorylated JMD1 [26],
the CRR3 hC and CRK1 hC peptides can bind to sACR4 KC (upper panel). Control blots show no specificity towards the SUMO solubility tag (lower panel).
(C) Peptide binding assay demonstrating the ‘KDSAF’ containing peptides can bind to the natively folded sACR4 KC protein immobilized on a Ni2+ coated
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containing peptides to the sACR4 KC, a protein lacking the JMD (Fig. 5B, upper panel). Impor-
tantly, the peptides do not bind to the SUMO protein used as a control (Fig. 5B, lower panel).
The presence of sACR4 KC or SUMO protein was verified by independent western blots using
anti-SUMO antibody (data not shown).
In a parallel experiment we determined peptide binding to sACR4 KC that was immobilized
on Ni2+ coated plates through the N-terminal histidine tag to ensure that the ‘KDSAF’ peptides
binding to sACR4 KC was not an artifact caused by nonspecific binding to a misfolded protein.
The data in Fig. 5C, demonstrates that all three ‘KDSAF’motif containing peptides are able to
bind to the sACR4 KC protein to different extents. The CRR3 and CRK1 hC peptides showed
the highest binding affinity to sACR4 KC and had similar binding capacity under our assay
conditions. The differences in binding affinities seen with these peptides suggest that variations
in the flanking residues of the core ‘KDSAF’motif may influence binding affinity. These pep-
tide binding results provide strong support for the involvement of the ‘KDSAF’ region in inter-
molecular contacts between ACR4 and CRR3 or CRK1 family members.
‘KDSAF’motif peptides show reduced binding to ACR4 kinase domain
containing mutations in the LLSLL region
Previously we demonstrated that the preferred binding site of the JMD1 peptide in ACR4 is
most likely in the N-terminal lobe of the kinase domain, potentially mediated by the LLSLL se-
quence [26]. To further validate this observation, we first expressed and purified a SUMO-
tagged mutant of the ACR4 kinase domain in which the LLSLL sequence was replaced with Ala
(s-KC-AAAAA). The CD spectrum of the mutant protein (Fig. 6A) attests to its proper folding.
The mutant protein was then immobilized on a Ni2+ coated plate and the binding of the
‘KDSAF’ peptides JMD1, pJMD1 (JMD1 with phosphorylated Ser475) and CRK1-hc measured
as described above (Fig. 6B). The significant decrease in binding ability to the mutant sKC-
AAAA compared with the control KC provides strong support for the involvement of LLSLL
region in intermolecular interactions between the ACR4 ICD and the kinase active members of
the AtCRR family.
ACR4 directly interacts with Transcription Factor WOX5
Previous reports have suggested a signaling module involving ACR4 and the WOX5 transcrip-
tion factor. WOX5 expression dynamics are proposed to be influenced by ACR4 acting
through the perception of a postulated CLE40 peptide ligand. ACR4 is primarily expressed in
the D1-D3 cell layers in the root tip, whereas WOX5 is solely expressed in quiescent center
(QC) [21–22, 41]. Overexpression of the CLE40 gene or application of exogenous CLE40 pep-
tide expands the ACR4 expression domain to include the QC [21–22]. We therefore hypothe-
sized that the ACR4 intracellular domain may have the capability to directly interact with
WOX5 and phosphorylate it, thus affecting WOX5 function inside the cell.
To examine the in vitro association of ACR4 with WOX5, we first incubated the purified
sACR4 and mWOX5 proteins together and used amylose resin to pull-down the mWOX5 pro-
tein. Additionally, in a parallel experiment, we determined the effect of autophosphorylation of
the ACR4 ICD on interaction with WOX5. Our results demonstrate that naïve ACR4 is indeed
pulled-down by mWOX5 protein (Fig. 7A, upper panel, lane 2, arrow) but this interaction is
abolished with phosphorylated ACR4 protein (Fig. 7B, upper panel, lane 2) indicating that
plate. Each peptide binding experiment was performed in triplicate and data represented as the mean ± the S.E. Data were corrected for dilution factor and
subtracting the absorbance of the control (SUMO) from the experimental samples.
doi:10.1371/journal.pone.0118861.g005
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Fig 6. Binding of ‘KDSAF’ peptides to sACR4 KC and sACR4 KC-AAAAA. (A) Conformational analysis of
sACR4 KC 9 (dashed line) and sACR4 KC-AAAAA (solid line) indicating that mutations did not cause protein
misfolding. Far UV CD spectra in 10 mM Tris (pH 7.4) and 0.1 mM TCEP with an A280 value of ~1.0. (B)
Peptide binding assay demonstrating the binding efficiency of ‘KDSAF’ containing peptides to the sACR4 KC
protein and sACR4 KC-AAAAA immobilized on a Ni2+ coated plate. The sACR4 KC-AAAAAmutant shows
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autophosphorylation is not a requirement for association. To unequivocally show that
mWOX5 was pulling out sACR4 (Fig. 7A, upper panel, lane 2, arrow), we performed a separate
western blot using anti-SUMO antibody (Fig. 7A, lower panel, lane 2). In addition, control re-
actions using either the SUMO or MBP solubility tags demonstrate the observed interaction
was specifically between the ACR4 ICD andWOX5 (Fig. 7A and B, lanes 3–5).
reduced binding affinities for ‘KDSAF’ containing peptides when compared to wild-type sACR4. Each peptide
binding experiment was performed in triplicate and data represented as the mean ± the S.E. Data were
corrected for dilution factor and subtracting the absorbance of the control (SUMO) from the
experimental samples.
doi:10.1371/journal.pone.0118861.g006
Fig 7. ACR4 ICD interaction with WOX5. The interaction between sACR4 and mWOX5 was determined by an in vitro pull-down assay. mWOX5 was
incubated in the presence of unphosphorylated or phosphorylated sACR4 in parallel experiments. In (A), mWOX5 can specifically bind and pull-down naïve
sACR4 (lane 2, arrow). An anti-SUMOwestern blot confirmed sACR4 binding (lower panel). In controls, no binding is observed to SUMO alone (lane 3) and
MBP does not bind to sACR4 (lane 4). In (B) mWOX5 cannot interact with autophosphorylated sACR4. In A and B, 12% SDS-PAGE separation of interacting
proteins (top panels) and anti-SUMOwestern blots of proteins from each reaction (lower panels).
doi:10.1371/journal.pone.0118861.g007
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Mapping of in vitroWOX5 phosphorylation sites
The in vivo expression patterns of WOX5 and ACR4 have been demonstrated to overlap in the
Arabidopsis root tip [21–22]. In addition, our pull-down studies indicate that the ICD of ACR4
can interact with WOX5. We therefore considered the possibility that the ACR4 kinase domain
could phosphorylate WOX5, thus affecting WOX5 function in the root. Transcription factors
can be regulated through reversible phosphorylation, therefore regulating their function inside
the cell. For example, STAT transcription factors can be directly phosphorylated by the EGF re-
ceptor kinase domain to modulate their DNA binding activity [42–43]. Thus, we incubated
sACR4 with mWOX5 in an in vitro kinase assay in the presence of [γ-32P] ATP. We clearly
demonstrate that WOX5 is phosphorylated by sACR4, in vitro (Fig. 8, lanes 2–4). Since sACR4
and mWOX5 have similar migration patterns on an SDS-PAGE gel, we wanted to ensure the
signal in the autoradiogram was due to WOX5 phosphorylation and not sACR4 autophosphor-
ylation. Therefore, after incubation, the phosphorylated mWOX5 protein was pulled-down by
amylose resin and extensively washed to remove autophosphorylated sACR4. Indeed, the ap-
pearance of the radioactive band was due to mWOX5 phosphorylation, as seen by the absence
of sACR4 when incubated alone (Fig. 8, lane 1). A separate control reaction performed under
the same conditions with sACR4 and MBP confirmed that the phosphorylation was specific to-
wards WOX5 and not the MBP solubility tag (Fig.8, lanes 5–7).
Fig 8. ACR4 can phosphorylate WOX. To demonstrate ACR4 phosphorylation of WOX5, sACR4 was incubated with mWOX5 in an in vitro kinase assay.
(A) An autoradiogram demonstrating phosphorylation of WOX5. The absence of sACR4 (10 μl load) is shown in lane 1. Phosphorylated mWOX5 (lanes 2–4)
was loaded at increasing amounts, 2, 5, and 10 μl of reaction per lane, respectively. A control reaction showing that the MBP tag cannot be phosphorylated
by ACR4 (lanes 5–7) was loaded at increasing amounts, 2, 5, and 10 μl of reaction per lane, respectively. (B) The corresponding coomassie stained gel.
doi:10.1371/journal.pone.0118861.g008
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We next determined the sites of phosphorylation within the WOX5 protein by collision in-
duced dissociation (CID) tandem mass spectrometry. The data dependent analysis of tryptic
peptides and a search against the mWOX5 protein sequence (Fig. 9A) yielded several phos-
phorylated peptides. Assignment of the phosphorylation site was performed by verifying the
presence of diagnostic site-discriminating y and b series ions. For example, the CID tandem
mass spectrum of the phosphopeptide encompassing the junction between the C-terminal end
Fig 9. Identification of in vitroWOX5 phosphorylation sites. (A) The sequence of the MBP fusedWOX5 protein is shown: the N-terminal MBP fusion tag
(grey italics) and the 182aaWOX5 sequence with the C-terminal 6X-His tag (black). Note, the N-terminal Met residue of WOX5 was changed to Gly.
Confirmed phosphorylation sites, Ser2, Ser4, Ser88, and Ser158 are boxed. The phosphopeptides identified by mass spectrometry are underlined. (B)
Collision-induced low resolution fragmentation spectrum of the phosphopeptide GSAGAALGSFSVK, encompassing the C-terminal end of the fusion tag and
the N-terminal end of WOX5. The presence of the phosphorylated b9 (theoreticalm/z 654.32, observedm/z of 654.33) and y5 (theoreticalm/z 549.30,
observedm/z of 549.33) ions, and the unphosphorylated b8 (theoreticalm/z 585.30, observedm/z of 585.17) and y4 (theoreticalm/z 480.28, observedm/z of
480.30) ions, confirms Ser2 as the site of phosphorylation.
doi:10.1371/journal.pone.0118861.g009
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of the solubility tag and the N-terminal sequence of WOX5, GSAGAALG(pS)FSVK, is shown
in Fig. 9B. The predominant species is the [M+2H-98]2+ ion (m/z of 567.3) carrying a +2
charge state. This is characteristic of a neutral loss of phosphoric acid which is indicative of a
phosphorylated peptide. Exact assignment of the phosphorylation at Ser2 (in WOX5 amino
acid sequence) was verified by the presence of site-discriminating ions including the phosphor-
ylated b9 (theoreticalm/z 654.32, observedm/z of 654.33) and y5 (theoreticalm/z 549.30, ob-
servedm/z of 549.33) ions and the unphosphorylated b8 (theoreticalm/z 585.30, observedm/z
of 585.17) and y4 (theoreticalm/z 480.28, observedm/z of 480.30) ion. The absence of the
phosphorylated b series of ions corresponding to b2-b8 and y series ions y3-y4, further con-
firmed that phosphorylation occurs at Ser2. A total of four phosphorylation sites were identi-
fied within the WOX5 sequence (Fig. 9A). Table 1 summarizes the site-discriminating ions for
the four confirmed sites at Ser2, Ser4, Ser88, and Ser158 of the WOX5 protein. Intriguingly,
phosphorylation at two Ser residues occurs in a ‘GSFS’motif within WOX5. ACR4 also con-
tains a ‘GSFS’ sequence located within the glycine-rich loop of the kinase structure and is
autophosphorylated at the first Ser [19]. Furthermore, a third phosphorylation site in WOX5,
Ser158, is found in a ‘TSFS’motif that is highly similar to the ‘GSFS’ sequence. These data sug-
gest a potential recognition motif for ACR4 substrate phosphorylation of WOX5 in vivo.
Discussion
In higher animals and plants, directed cell proliferation, specification, and differentiation dur-
ing growth and development are guided by a variety of external stimuli that are perceived and
interpreted by a multitude of cell surface receptors primarily mediated through RTKs in ani-
mals and by RLKs in plants. The accepted paradigm of signal transduction involves ligand per-
ception/binding to the extracellular domain, activation of the intracellular kinase domain and
subsequent activation of downstream signaling pathways through reversible phosphorylation
events. Subsequently, downstream signaling components influence transcriptional activity in
the nucleus allowing appropriate cellular responses to specific signaling cues.
In recent years, however, it has become apparent that the concept of a single receptor-single
ligand interaction is perhaps too simplistic. Thus, structural, biophysical, biochemical and
functional studies of several RTKs such as the Epidermal Growth Factor Receptor (EGFR) fam-
ily [10–12, 44], Somatostatin and Opioid receptors [45], Insulin-like Growth Factor Receptor
[46], and Platelet-derived Growth Factor (PDGF) [47] have demonstrated the capacity of these
RTKs to assemble as homo- or heterodimeric complexes with distinct ligand specificity/affini-
ties and downstream signaling activity. Similar heteromeric interactions occur among RLKs
such as FLS2 and BAK1 [48], CLAVATA2 [49], and BRI1 [13–14] and their impact on
Table 1. Site-discriminating ions in WOX5 MS (the percentage of maximal intensity for each site-discriminating ion in the averaged low-
resolution CID spectrum is shown in parenthesis.
Peptide Residue Position in
WOX5
b ion Phosphorylated b
ion
y ion Phosphorylated y
ion
GSAGAALGSFSVK 2 b8 (+1, 6.45) b9 (+1, 4.42) y4 (+1, 6.50) y5 (+2.41)
GSAGAALGSFSVKGR 4 b10 (+1,
5.22)
b11 (—) * y4 (+2, 2.54) y5 (+2, 1.79)
KISIDFDHHHHQPSTR 88 b2 (+1, 0.40) b3(+1, 0.92) y13 (+2, 1.30) y14 (+2, 3.74)
ETTTTSFSPYSSCGAEMEHPPPLDLR 158 b5 (+1, 2.50) b6 (—) * y20 (+2,
16.59)
y21 (+2, 4.06)
*supporting ion information is available)
doi:10.1371/journal.pone.0118861.t001
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downstream signaling cascades is well established. Importantly, in a recent study Stahl et al
[24] have provided evidence from in planta studies that CLV1, an RLK essential for shoot stem-
ness maintenance, can also moderate root stemness in Arabidopsis through homo- and hetero-
meric complexes with ACR4. This study not only documented the overlapping expression
patterns of the two RLKs in the distal root meristem using reporter lines but unequivocally
demonstrated their association with the plasmodesmata. Significantly, it was demonstrated
through a split-luciferase assay and FRET-FLIM analysis that direct molecular interactions be-
tween ACR4 and CLV1 occurred at the plasmamembrane and was mediated through the
transmembrane domains.
Among the five members of the ACR4 receptor family, limited genetic and cell biology anal-
yses have suggested these receptors may act in the same genetic pathway through functional re-
dundancy based upon gene duplication and/or through activation of signaling cascades via
receptor heterodimerization [15, 17, 20]. RT-PCR studies of ACR4 and CRR transcript levels
in varying tissues encompassing the entire Arabidopsis plant demonstrate all family members
are expressed within all tissues examined, except for CRR2 and CRK1 which are not expressed
in the siliques [17]. However, since physically interacting proteins must be spatiotemporally
co-expressed in the same milieu to have any biological relevance, gene expression analysis
often serves as a proxy for protein expression [50]. In the absence of reporter lines to experi-
mentally demonstrate overlapping protein expression, we used two in silico gene expression
data sets to compare the mRNA levels of members of the ACR4 family in vegetative tissue and
roots. Thus, analysis of the microarray data for various tissues/cell types in Arabidopsis at the
Arabidopsis “electronic fluorescent pictograph” (eFP) browser (http://bar.utoronto.ca) [51],
very clearly indicated overlapping expression patterns for this family in the shoot apical meri-
stem (SAM), stem epidermis (top of stem) and stigma/ovaries. Within the SAM, all five genes
(ACR4, At3g59420; AtCRR1, At3g09780; AtCRR2, At2g39180; AtCRR3, At3g55950; AtCRK1,
At5g47850) were expressed in the rib meristem and the peripheral zone with mRNA expres-
sion levels in the order ACR4>AtCRR2>AtCRR1>AtCRR3>AtCRK1. Interestingly, however,
in the central zone there appeared to be very little expression of AtCRK1 although the expres-
sion levels of the other 4 genes followed the same order. A similar expression profile was ob-
served in the stem epidermis (top of stem) and stigma/ovaries, but with non-detectable mRNA
for AtCRK1 (data not shown). In analogous fashion we applied the co-expression analysis tool
within CORNET 2.0 (https://cornet.psb.ugent.be/) [52, 53] specifically with the data set for ex-
pression in root. It is both significant and interesting that all five genes showed overlapping
and comparable expression levels in the quiescent center, lateral root cap, root tip, root cortex
and columella root cap cell (data not shown). Therefore, existing data showing overlapping tis-
sue-level expression patterns leave open the possibility that the proteins could be co-expressed
in the same cells and interact in vivo towards defined biological pathways.
In this study we have analyzed the in vitro interactions between the ICDs of ACR4 and the
CRRs to elucidate the molecular aspects of protein-protein interactions among the kinase do-
mains of this receptor family. Ideally, crystal structure determination of complexes between
ACR4 and the CRRs would facilitate an atomistic level understanding of these interactions. In
the absence of structural information, we utilized hydrodynamic analyses, peptide binding
studies and pull-down assays to demonstrate protein-protein interactions among members of
the ACR4 family. Gel filtration studies and pull-downs show that, in the unphosphorylated
state, the ICD of ACR4 can self-associate (Fig. 1A and Fig. 2A, lane 1) and also bind to all four
CRR ICDs (Fig. 1B and D and Fig. 2A), thus indicating that the intracellular regions of these re-
ceptors have the potential to form inactive heteromeric complexes. Indeed, examples exist in
which RTKs are capable of preformed, inactive heterodimer complexes in a ligand independent
manner. For instance, the EGFRs are able to form homo- or heterodimeric structures via their
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kinase domains in the absence of external signaling molecules [54–58]. Among RLKs, prece-
dent for a heteromeric interaction exists in the five member AtSERK family, wherein AtSERK1
is able to heterodimerize with AtSERK2 in cowpea protoplasts [59]. Interestingly, the ICDs of
CRR2, CRR3, and CRK1 do not show evidence of homodimerization (Fig. 1B, C, and D, right
panels) although it is possible that they may have the capacity to form heteromers amongst
themselves. Overall, given the ACR4-CLV1 interaction, it will be particularly interesting to see
if the paradigm of heteromeric interactions holds for the ACR4 homologs as well. Such focused
studies on the molecular basis of protein-protein interactions using in vitro biophysical/bio-
chemical systems can inform on formulating new hypothesis-driven biological investigations.
We have also demonstrated that the ICD of ACR4 is capable of binding to the kinase-dead
CRR1 and CRR2 ICDs regardless of the phosphorylation status (Fig. 2A-D). This observation
is particularly interesting in light of the fact that in animals there are atypical RTKs with ki-
nase-inactive domains that signal through phosphorylation-independent mechanisms [60]. A
classic example is the ErbB3 receptor in the EGFR family that has a weakly active or non-func-
tional kinase domain but is nevertheless a critical component of the EGFR signaling mecha-
nism since it can form heterodimers with other members of the family that phosphorylate it
[12, 61]. Atypical RLKs, functioning in an analogous manner, have also been reported in
plants. Sequence analysis suggests that ~20% of the>600 RLKs encoded in the Arabidopsis ge-
nome are inactive, atypical RLKs, and it is likely that activation of differential signaling path-
ways can occur through heterodimerization among this RLK subfamily [34, 62–63]. Therefore,
it is quite possible for ACR4 to expand its signaling cascade through interactions with the ki-
nase-dead homologs.
Our in vitro kinase assays demonstrate that active ACR4 kinase domain can phosphorylate
the ICDs of all the CRR homologs, therefore suggesting that ACR4 signaling in vivo could po-
tentially occur through heterodimerization with CRR family members. Similar mechanisms
have been determined in plant RLKs in which cytoplasmic domains in heterodimeric receptor
complexes can undergo trans phosphorylation [31, 64–65]. Importantly, binding of different li-
gands to the ACR4 extracellular domain may also promote preferred heterodimerization with
CRR family members to initiate a diverse array of signaling pathways that could alter signaling
output and duration. For instance, members of the EGF receptor family can bind a variety of li-
gands which promotes homo- or heterodimerization that can activate multiple downstream
signaling cascades [10, 12]. Although one peptide, CLE40, has been proposed to be the ligand
for ACR4 [21–22], it does not preclude the possibility that other ligands may act in the ACR4
signaling pathway. Indeed, there are 32 members of the CLE peptide family in Arabidopsis that
affect developmental functions in the plant [66,67]. However, the role of these presumed pep-
tide ligands in ACR4 or CRR signaling has yet to be determined.
Both intramolecular and intermolecular protein-protein interactions are driven by contacts
between specific residues on the interfacial faces of the participating domains. In contrast to
stable complexes, biological signal transduction is regulated in large part by transiently formed
states in which the proteins may switch between bound and unbound forms through modifica-
tion-dependent conformational changes. While it is not possible to accurately define the state
of the ACR4/AtCRR interactions based on current data, nevertheless our peptide-binding and
HD exchange experiments indicate the importance of the N-lobe region of ACR4 kinase do-
main in heteromeric interactions. Specifically, our results suggest that the KDSAF motif in
CRR3/CRK1 is important for contacts to the LLSLL region in ACR4 ICD (Fig. 6) and is further
supported by the fact that this binding is significantly reduced when these residues are mutated
to alanines (Fig. 8). Furthermore, our HDX studies indicate protection of solvent accessible re-
gion FRTELDL, which is in close proximity to the LLSLL region at the helix-C of ACR4 ICD in
a 3DModel (data not shown). Interestingly, in the case of the RTKs, the involvement of the N-
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lobe in modulation of kinase activity, intermolecular and intramolecular interactions is well
documented [1, 68–70, 71, 72].
It appears that ACR4 is involved in at least two distinct signaling pathways with overlapping
themes, stem cell differentiation in the root tip and differentiation of the epidermis in vegeta-
tive and reproductive tissue. As a mediator of stem cell differentiation in the root tip (20–22),
ACR4 is described to perceive the extracellular CLE40 peptide ligand which promotes stem cell
differentiation. Presumed activation of ACR4 then influences the expression domain of the
WOX5 transcription factor, a protein that promotes stem cell proliferation. Our experiments
have demonstrated that the ACR4 kinase can interact with and phosphorylate WOX5 in vitro.
At this time, the relevance of these phosphorylation sites to the in vivo function of WOX5 is
not known. Complementary in vivo experiments knocking out the potential phosphorylation
sites in the WOX5 protein may drive phenotypic effects in transformed wox5mutant plants
aiding in the characterization of the functional significance of these phosphorylated residues.
However, although WOX5 is deemed to be a key player in root stem cell regulation, it would be
presumptuous to ignore the parallel inputs derived from other transcription factors [73] or po-
tential regulation influenced by the combinatorial activity of different transcription factors
[74].
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